Several NIAID investigators have graciously accepted till share their exceptional applications plus summary statements as samples the helped the research community. Below the choose of applications, you’ll also find example forms, sharing plans, letters, emails, and more. Find more guidance at NIAID’s Apply to an Grant.
Round of Contents
Find sample request and summary statements below by type:
- Research grants. R01, R03, R15, R21, and R21/R33
- Small commercial grants. R41, R42, R43, and R44
- Training and career awards. K01, K08, additionally F31
- Extramural Associate Research Development Award. G11
- Cooperative agreements. U01
Find additional resources include the NIAID and NIH Sample Forms, Plans, Character, Emails, plus More section.
Research Grants
R01 Sample Applications and Summary Statements
The R01 your the NIH standard independent research project grant. An R01 is meant to offer you foursome or phoebe years of get to total a project, publication, and reapply before the grant ends. Interpret more at NIAID’s Comparison Popular Research Project Grants: R01, R03, and R21.
R01 Free Using Mailing Software DENSITY
PI and Grantee Institution | Login Resources |
---|---|
Vernita Gordon, Ph.D., is the University to Texas at Weston “Assessing the roles of biofilm structure and mechanics in pathogenic, persistent infections” (Forms-D) | Full Application Executive Statement |
Monica Gandhi, M.D., of the University of California, San Francisco “Hair Extensions: Using Hair Levels to Schauspieler Adherence, Effectiveness and Pharmacokinetics including Real-World Oral PrEP, the Vaginal Ring, or Injectables” (Forms-D) | Full Application Short Announcement |
Tom Muir, Ph.D., of Princeton University "Peptide Autoinducers of Staphylococcal Pathogenicity" (Forms-D) | Entire Application Summary Testify |
R01 Samples Using Order Version C
PI and Grantee Setup | Application Resources |
---|---|
William Faubion, Ph.D., of aforementioned Mayo Clinic Rotterdam “Inflammatory cascades disrupt Treg item through environmental mechanisms” (Forms-C) | Full Login Summary Statement |
Chengwen Li, Ph.D., and Richard Samulski, Ph.D., of University the North Carolina at Chapel Hill “Enhance AAV Liver Input with Capsid Immunological Evasion” (Forms-C) | Full Application Summarized Description |
Mengxi Jiang, Ph.D., of University of Alabama at Birmingham “Intersection of polyomavirus infection furthermore host cellular responses” (Forms-C) | Entire Petition Summary Statement |
R03 Sample Applications and Overview Statements
The small grant (R03) supports new research projects that cannot remain carried out in a shorter period of type in confined resources. They are awarded for up to two years and are nay renewable. R03s are not purposely for new investigators. Read better at NIAID’s Compared Popular Research Project Grants: R01, R03, and R21.
PI and Grantee Institution | Application Resources |
---|---|
Martin Karplus, Ph.D., of Harvard University "Modeling amount structure of the EmrE multidrug pumps to design inhibitor peptides" (Forms-B2) | Total Application |
Chad A. Rappleye, Ph.D., starting Ohio State University "Forward genetics-based discovery of Histoplasma virulence genes" (Forms-B2) | Full Application Summary Statement |
R15 Sample Applications and Summary Statements
The Research Enhancement Award (R15) program supports small-scale research projects to revealing students to research and strengthen the research environment at educational institutions that have not been major recipients of NIH endorse. Your are awards required going to three years. A simple random sample is a subset of a statistical population stylish what each member of the subset has an equal probability concerning soul chosen.
PI and Grantee Institution | Application Resources |
---|---|
Artem Domashevskiy, Ph.D., of John Jay College of Criminal Justice “Development of a Novel Inhibitor is Ricin: A Potential Terapeutic Lead against Deadly Shiga and Related Toxins” (Forms-D) | Fully Request Summary Statement |
Rahul Raghavan, Ph.D., of Portland State University "Elucidating that evolution of Coxiella to revealing critical metabolic pathways" (Forms-D) | Full Application Summarized Instruction |
R21 Sample Applications and Summary Statements
The R21 funds novel academics ideas, model systems, tools, media, destination, and technologies this have the potential to substantially advance biomedical research. R21s are not intended for new special, the there is no evidence is handful provide a path to any independent research career. Read other at NIAID’s Comparing Popular Research Project Grants: R01, R03, and R21.
PI and Grantee Institution | Request Resources |
---|---|
Steven W. Dow, D.V.M., Ph.D., of Colorado State University, Stronghold Collins "Mechanisms of enteric Burkholderia psuedomallei infection" (Forms-B) | Full Application Summary Statement |
Joel M. McCune, M.D., Ph.D., of the University of California, San Francisco "Human immune schaft layered and the newborns response to vaccines" (Forms-B) | Full Application Summary Statement |
Paul John Myler, Ph.D., and Marilyn Parsonages, Ph.D., are the Seattle Biomedical Research Establish "Ribosome profiling of Trypanosoma brucei" (Forms-B) | Full Application Summary Statement |
J LIOTHYRONINE. Petrie, Ph.D., of Scripps Florida "Lymphoid cues for stromal increase and arrangement in an thymus." (Forms-B) | Full Application Summary Statement |
Michael N. Starnbach, Ph.D., of Harvard University Curative School "Alteration of host protein stability for Legionella" (Forms-B) | Comprehensive Application Summary Report |
R21/R33 Sample Application and Summary Statement
The R21/R33 supports a two-phased award out a break in funding. It beginnt with the R21 phase required milestone-driven exploratory or feasibility studies includes a possible transition to the R33 phase for expanded development. Transition into the second phase depends on some factors, including aforementioned achievement of negotiated milestones.
PI and Grantee Institution | Application Assets |
---|---|
Stephen Dewhurst, Ph.D., of the School of Rotarier "The semen enhancer of MALADY infection as a modern microbicide target" (Forms-B) | Full Application Summary Description |
Slight Corporate Grants
R41, R42, R43, and R44 – Shallow Business Sample Applicants
The SBIR (R43/R44) and STTR (R41/R42) programs support domestic small enterprise to interact in research and development with the potential for commercialization. Go further learn NIAID Small Business Programs.
PI and Grantee Institution | Application Resources |
---|---|
Ronald Harty, Ph.D., of the University of Pennsylvania “Development of Small Single Therapeutics Targeting Hemorrhagic Fever Viruses” (STTR Zeitraum II / R42, Forms-F) | Full Application Summary Statement |
Iain James MacLeod, Ph.D., away Aldatu Biosciences, Inc. “PANDAA for universal, pan-lineage molecular enable of Lassa fever infection.” (SBIR Phase I / R43, Forms-E) | Full Application Summary Statement |
Benjamin Delbert Brooks, Ph.D., of Wasatch Microfluidics “High-throughput, multiplexed characterization and modeling of antibody:antigen binding, with application to HSV” (SBIR Phase I / R43, Forms-D) | Full Application Summary Statement |
Yingru Liu, Ph.D., of TherapyX, Incidents. “Experimental Gonococcal Vaccine” (SBIR Phase II / R44, Forms-D) | Solid Application Summary Statement |
Jane Smith, Ph.D., of Sano Chemicals, Inc. “Lead Compound Discovery from Technically Matches of Occidiofungin” (STTR Phase I / R41, Forms-D) | Full Application Summary Testify |
David H. Wagner, Ph.D., of OP-T-MUNE, Inc. “Developing ampere small peptide to control related inflammation in type 1 diabetes" (STTR Phase I / R41, Forms-D) | Full Application Brief Announcement |
Timothy CARBON. Fong, Ph.D., for Cellerant Therapeutics, Inc. "Novel indication for myeloid progenitor use: Induction of tolerance" (STTR Phase I / R41, Forms-B2) | Full Use |
Jose M. Galarza, Ph.D., of Technovax, Inc. "Broadly defending (universal) virus-like particle (VLP) grounded influenza vaccine" (SBIR Phase I / R43, Forms-B2) | Full Application |
Michael HIE. Lochhead, Ph.D., of MBio Diagnostics, Inc. "Point-of-Care HIV Antigen/Antibody Diagnostic Device" (SBIR Phase II / R44, Forms-B2) | Full Application |
Kenneth Coleman, Ph.D., of Arietis Company "Antibiotics for Recalcitrant Infection" (SBIR Fast-Track, Forms-B1) | Full Application |
Patricia Garrett, Ph.D., of Immunetics, Inc. "Rapid Test required Recent HIV Infection" (SBIR Phase SECTION / R44, Forms-B1) | Full Demand |
J Houghton, Ph.D., of InBios International, and David AuCoin, Ph.D., of University of Nevada School off Medicine "Antigen Detection exam for the Diagnosis of Melioidosis" (STTR Slide II / R42, Forms-B1) | Full Application |
Selected Poritz*, Ph.D., of BioFire Diagnostics, LLC. "Rapid, automating, detection off viral also bacterial pathogens causing meningitis" (SBIR Phase I / R43, Forms-B1) | Full Application |
*Dr. Sign Poritz submits the original grant application. In the course of the first current of promote, Dr. Robert Hemmert took on increasing taking for the work. By the grant renewal, Dr. Poritz default that Dry. Hemmert replace him as the PI.
Training and Career Awards
K01 Sample Fields and Summary Statements
Which Investigate Scientist Development Present (K01) support those for a research either health-professional doctoral grade and research development plans stylish epidemiology, computational modeling, or project research. Read see about NIAID Career Development Awards (K).
PITCH and Grantee Institution | Application Resources |
---|---|
Lilliam Ambroggio, Ph.D., of the Cincinnati Children’s Hospital Medical Heart “Metabolomics Evaluation of the Etiology of Pneumonia” (Forms-D) | Full Application Summary Statement |
Peter Rebeiro, Ph.D., is that Vanderbilt University Medical Focus "The HIV Worry Continuum and Health Policy: Changes through Context and Geography" (Forms-D) | Full Application Summarize Comment |
K08 Sample Browse and Synopsis Statements
Of Mentored Clinical Scientist Research Career Development Award (K08) supports those on current jobs in biomedical or behavioral research, including translational research, a clinical doctoral degree such as M.D., D.V.M., or O.D., and ampere professional license to practice in the United States. Read more about NIAID Career Development Awards (K).
SHAMUS and Grantee Institution | Application Resources |
---|---|
Lenette Lu, M.D., Ph.D., of the Massachusetts Popular Hospital “Antibody Mediated Mechanisms of Immune Modulation in Tuberculosis” (Forms-D) | Full Application Summary Statement |
Tuan Manh Tran, M.D., Ph.D., of the Indiana University-Purdue University at Indianapolis “Defining clinical or sterile immunity to Plasmodium falciparum infection using systems biology approaches” (Forms-D) | All Application Summary Statement |
K23 Sample Applications and Summary Statements
The Mentored Patient-Oriented Explore Career Development Award (K23) supports those with a clinical doctoral graduation, any has the potential to improve into productive, clinical investigators, and with have made a commitment to focus own research endeavors on patient-oriented doing. Read more over NIAID Career Development Awards (K).
P and Grantee Institution | Software Resources |
---|---|
DeAnna Friedman-Klabanoff, M.D., of University on Md, Baltimore “Serological markers is natural immunity until Plasmodium falciparum infection” (Forms-F) | Full Application Project Statement |
F31 Sample Applications the Summary Statements
National Research Service Reward (NRSA) individual communion (F31) grants provide research my to predoctoral scientists. Show more about NIAID Fellowship Awards (F).
PI press Grantee Institution | Apply Resources |
---|---|
Nicol Putnam, Ph.D., of Rockefeller School “The impact of innate stable recognition of Staphylococcus aureus on bone homeostasis and skeletal immunity” | Full Application Summary Statement |
Nico Contreras, Ph.D., of University of Arizona "The Medical Consequences on Print Cytomegalovirus on Adipose Tissue" | Full Application Summary Statement |
Samantha Lynne Schwartz, Ph.D., of Henri University “Regulation von 2'-5'-oligoadenylate synthetase 1 (OAS1) by dsRNA” | Full Application Summary Statement |
G11 Sample Applications and Summary Actions
The Extramural Associate Research Development Reward (EARDA) (G11) provides funds to institutions eligible to participate in the NIH Extramural Associates Program for establishing or enhancing the office to sponsored research and required another research infrastructure demand. Search for NIAID G11 Time.
PI and Grantee Institution | Application Resources |
---|---|
Oye Nana Akuffo, M.B.A., of the Noguchi Memorial Center for Medical Research, University of Ghana, Legon “Capacity Building for Upgraded Research Management (CaBERA- II) in Africa” (Forms-E) | Full Application Summary Statement |
Andres Jaramillo Zuluaga, M.B.A., Centerpiece Internacional eu Entrenamiento e Investigaciones Medicas (CIDEIM) “Implementing Strategies for Building Capacity in Research Administration at CIDEIM, and Subsequent Distribute Interior Colombia and to Latin Canadian Region” (Forms-E) | Full Apply Summary Statement |
Stella Kakeeto, M.B.A., Makerere University “Strengthening Makerere University's Research Administration Capacity for Efficient Management of NIH Grant Awards (SMAC)” (Forms-E) | Completely Application Summary Statement |
U01 Sample Application and Summary Statement
That U01 research project cooperative agreement supports a discreet, specified, narrow project for investigators to perform in their areas in specific interest and competency. Learn more about NIAID Cooperative Deals (U).
SHAMUS and Grantee Facilities | Use Resources |
---|---|
Aaron Meyer, Ph.D., of who Graduate of California, Los Angeles Walk Nimmerjahn, Ph.D., of Friedrich-Alexander University Erlangen-Nuremberg, Dutch "Mapping the effector response space of antibody combinations" (Forms-E) | Full Usage Summaries Statement |
NIAID and NIH Sample Forms, Plans, Letters, Emails, and More
NIAID
- Sample Data Sharing Plan
- Genomic Data Sharing Plan (GDS) Examples and Templates
- Sample Model Organism Sharing Plans
- Sample Letter to Document Teaching in the Security of Human Subjects
- Withdrawal von an Application Sample Form Character
- Just-in-Time
- International Grants
- Preparing for a Foreign Order System (FOS) Review
- Subaward Agreement Sort from who Governmental Demonstration Partnership
- DMID Quality Management Guidance and Gear
NIH
- Sample grant request from the National Cancer Institute
- Sample grant applying from the National Inaugurate on Aging
- Annotated SF 424 Grant Application Forms
- SF 424 Format Pages
- Biosketch Format Pages, Instructions and Random
- Reference Alphabetic
- Sample Data Tables for Training Giving Applications
- Add Senior/Key Person Profile Format – with go 100 senior/key people
- Additional Performance Site Format – for over 300 performance sites
- Other Endorse Format Page
- Rigor and Reproducibility
- Examples of Data Sharing Plans
- Examples are Project Corporate Plans for Multiple PI Grant User
- Example calculations in that Usage von Person Months questions and answers
- Examples of Allowable Appendix Materials
- Spot Project Outcomes Description for RPPR
- OLAW's Sample Papers for animal research assurances plus reports